quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:01·231d
SECFiling
MEI Pharma Inc. logo

MEI Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

MEIP· MEI Pharma Inc.
Health Care
Original source

Companies

  • MEIP
    MEI Pharma Inc.
    Health Care

Recent analyst ratings

  • Jul 23UpdateLaidlaw-
  • Mar 25UpdateJefferies$1.00
  • Mar 25UpdateWells Fargo$2.00
  • Mar 25UpdateStifel$2.00
  • Feb 3UpdateJefferies$4.00

Related

  • SEC220d
    MEI Pharma Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
  • INSIDER225d
    New insider Schornstein Alexander claimed ownership of 4,365,472 shares (SEC Form 3)
  • SEC225d
    MEI Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR225d
    MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker 'LITS'
  • SEC228d
    SEC Form EFFECT filed by MEI Pharma Inc.
  • SEC230d
    SEC Form 424B3 filed by MEI Pharma Inc.
  • SEC240d
    Amendment: SEC Form S-3/A filed by MEI Pharma Inc.
  • INSIDER246d
    SEC Form 4 filed by Director Riezman Joshua
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022